Multiple myeloma diagnostic criteria: Difference between revisions

Jump to navigation Jump to search
Line 9: Line 9:


===Revised Criteria for the Diagnosis of Multiple Myeloma===
===Revised Criteria for the Diagnosis of Multiple Myeloma===
The diagnosis of multiple myeloma requires the following:<ref name="lancet">Rajkumar, S. Vincent, Meletios A. Dimopoulos, Antonio Palumbo, Joan Blade, Giampaolo Merlini, María-Victoria Mateos, Shaji Kumar et al. "International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma." The Lancet Oncology 15, no. 12 (2014): e538-e548</ref>
The [[diagnosis]] of [[multiple myeloma]] requires the following:<ref name="lancet">Rajkumar, S. Vincent, Meletios A. Dimopoulos, Antonio Palumbo, Joan Blade, Giampaolo Merlini, María-Victoria Mateos, Shaji Kumar et al. "International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma." The Lancet Oncology 15, no. 12 (2014): e538-e548</ref>
*≥10% clonal plasma cells in bone marrow  
*≥10% clonal [[plasma cells]] in [[bone marrow]]
'''OR'''
'''OR'''
*biopsy-proven bony or extramedullary plasmacytoma,
*[[biopsy]]-proven bony or [[Plasmacytoma|extramedullary plasmacytoma]],
'''With''' one or more of the CRAB features and myeloma-defining events:
'''With''' one or more of the CRAB features and [[Multiple myeloma|myeloma]]-defining events:
*CRAB features:
*CRAB features:
**'''Hypercalcemia''': serum calcium >0·25 mmol/L (>1 mg/dL) higher than the upper limit of normal or >2·75 mmol/L (>11 mg/dL)
**'''[[Hypercalcemia]]''': [[Calcium|serum calcium]] >0·25 mmol/L (>1 mg/dL) higher than the upper limit of normal or >2·75 mmol/L (>11 mg/dL)
**'''Renal insufficiency''': creatinine clearance <40 mL per min or serum creatinine >177 μmol/L (>2 mg/dL)
**'''[[Renal insufficiency]]''': [[creatinine]] clearance <40 mL per min or [[serum creatinine]] >177 μmol/L (>2 mg/dL)
**'''Anemia''': hemoglobin value of >2 g/dL below the lower limit of normal, or a hemoglobin value <10 g/dL
**'''[[Anemia]]''': [[hemoglobin]] value of >2 g/dL below the lower limit of normal, or a [[hemoglobin]] value <10 g/dL
**'''Bone lesion''': one or more osteolytic lesions on skeletal radiography, CT, or PET-CT
**'''[[Bone]] [[lesion]]''': one or more osteolytic [[lesions]] on [[Skeleton|skeletal]] [[radiography]], [[CT-scans|CT]], or [[PET scan|PET-CT]]
*Myeloma-defining events:
*Myeloma-defining events:
**'''Bone marrow plasma cell burden''': Clonal bone marrow plasma cell percentage ≥60%
**'''[[Bone marrow]] [[plasma cell]] burden''': Clonal [[bone marrow]] [[plasma cell]] percentage ≥60%
**'''Free light chain ratio''': Involved-to-uninvolved free light chain ratio ≥100
**'''[[Light chain|Free light chain]] ratio''': Involved-to-uninvolved free [[light chain]] ratio ≥100
**'''MRI''': >1 focal bony lesion of 5mm or greater on MRI studies
**'''[[MRI]]''': >1 focal [[Bone|bony]] [[lesion]] of 5mm or greater on [[MRI]] studies
{| class="wikitable"
{| class="wikitable"
|+
|+
Line 28: Line 28:
|-
|-
|
|
*≥10% clonal plasma cells in bone marrow  
*≥10% clonal [[plasma cells]] in [[bone marrow]]
'''OR'''
'''OR'''
*biopsy-proven bony or extramedullary plasmacytoma
*biopsy-proven bony or [[Plasmacytoma|extramedullary plasmacytoma]]
'''With''' one or more of the following:
'''With''' one or more of the following:
*'''Hypercalcemia''': serum calcium >0·25 mmol/L (>1 mg/dL) higher than the upper limit of normal or >2·75 mmol/L (>11 mg/dL)
* '''[[Hypercalcemia]]''': [[Calcium|serum calcium]] >0·25 mmol/L (>1 mg/dL) higher than the upper limit of normal or >2·75 mmol/L (>11 mg/dL)
*'''Renal insufficiency''': creatinine clearance <40 mL per min or serum creatinine >177 μmol/L (>2 mg/dL)
 
*'''Anemia''': hemoglobin value of >2 g/dL below the lower limit of normal, or a hemoglobin value <10 g/dL
*'''[[Renal insufficiency]]''': [[creatinine]] clearance <40 mL per min or [[serum creatinine]] >177 μmol/L (>2 mg/dL)
*'''Bone lesion''': one or more osteolytic lesions on skeletal radiography, CT, or PET-CT
*'''[[Anemia]]''': [[hemoglobin]] value of >2 g/dL below the lower limit of normal, or a [[hemoglobin]] value <10 g/dL
*'''Bone marrow plasma cell burden''': Clonal bone marrow plasma cell percentage ≥60%
*'''[[Bone]] [[lesion]]''': one or more osteolytic [[lesions]] on [[Skeleton|skeletal]] [[radiography]], [[CT-scans|CT]], or [[PET scan|PET-CT]]
*'''Free light chain ratio''': Involved-to-uninvolved free light chain ratio ≥100
 
*'''MRI''': >1 focal bony lesion of 5mm or greater on MRI studies
*'''[[Bone marrow]] [[plasma cell]] burden''': Clonal [[bone marrow]] [[plasma cell]] percentage ≥60%
*'''[[Light chain|Free light chain]] ratio''': Involved-to-uninvolved free [[light chain]] ratio ≥100
*'''[[MRI]]''': >1 focal [[Bone|bony]] [[lesion]] of 5mm or greater on [[MRI]] studies
|}
|}


Line 68: Line 70:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
;[[Category:Disease]] [[Category:Hematology]] [[Category:Types of cancer]]   [[Category:Up-To-Date]] [[Category:Oncology]] [[Category:Medicine]] [[Category:Neurology]] [[Category:Neurosurgery]]
;[[Category:Disease]]   [[Category:Hematology]]   [[Category:Types of cancer]]   [[Category:Up-To-Date]]   [[Category:Oncology]]   [[Category:Medicine]]   [[Category:Neurology]]   [[Category:Neurosurgery]]

Revision as of 14:58, 7 November 2018

Multiple myeloma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple Myeloma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Multiple myeloma diagnostic criteria On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple myeloma diagnostic criteria

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple myeloma diagnostic criteria

CDC on Multiple myeloma diagnostic criteria

Multiple myeloma diagnostic criteria in the news

Blogs on Multiple myeloma diagnostic criteria

Directions to Hospitals Treating Multiple myeloma

Risk calculators and risk factors for Multiple myeloma diagnostic criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Hannan Javed, M.D.[2] Associate Editor(s)-in-Chief: Serge Korjian M.D. Shyam Patel [3]

Overview

The diagnosis of monoclonal gammopathy of undetermined significance requires the presence of clonal plasma cells < 10% and serum monoclonal protein <3g/dl but the absence of end-organ damage. The diagnosis of smoldering multiple myeloma requires the presence of clonal plasma cells 10%-60% and serum monoclonal protein >3g/dl but the absence of end-organ damage. The diagnosis of active multiple myeloma requires the presence of end-organ damage. In November 2014, the International Myeloma Working Group (IMWG) updated the criteria for the diagnosis of multiple myeloma to include novel validated biomarkers to better encompass the extent of disease. Prior to 2014, the original diagnostic criteria for end-organ damage included CRAB features (hypercalcemia, renal failure, anemia, and bone lesions) without consideration of the plasma cell burden or free light chain ratio. The 2014 update also clarified the underlying laboratory and radiographic findings of CRAB features, as well as the histological and monoclonal protein requirements for the disease diagnosis.[1]

Diagnostic Criteria

Revised Criteria for the Diagnosis of Multiple Myeloma

The diagnosis of multiple myeloma requires the following:[1]

OR

With one or more of the CRAB features and myeloma-defining events:

Revised Criteria for the Diagnosis of Multiple Myeloma

OR

With one or more of the following:

Criteria for the Diagnosis of Monoclonal Gammopathy of Undetermined Significance (MGUS)

All three criteria must be met:

  • Presence of serum monoclonal protein (IgG or IgA) <3 g/dL
  • Presence of bone marrow clonal plasma cells <10%
  • Absence of multiple myeloma-defining events or amyloidosis

Criteria for the Diagnosis of Smoldering Multiple Myeloma

Both criteria must be met[1]:

  • Serum monoclonal protein (IgG or IgA) ≥3 g/dL or urinary monoclonal protein ≥500 mg per 24 h and/or clonal bone marrow plasma cells 10–60%
  • Absence of multiple myeloma-defining events or amyloidosis

Revised Criteria for the Diagnosis of Multiple Myeloma

Both criteria must be met:[1]

  • ≥10% clonal expansion of bone marrow plasma cells or biopsy-proven bony or extramedullary plasmacytoma, and one or more of the following 7 features:
  • Evidence of end organ damage that can be attributed to the underlying plasma cell proliferative disorder:
  • Hypercalcemia: serum calcium >0·25 mmol/L (>1 mg/dL) higher than the upper limit of normal or >2·75 mmol/L (>11 mg/dL)
  • Renal insufficiency: creatinine clearance <40 mL per min or serum creatinine >177 μmol/L (>2 mg/dL)
  • Anemia: hemoglobin value of >2 g/dL below the lower limit of normal, or a hemoglobin value <10 g/dL
  • Bone lesion: one or more osteolytic lesions on skeletal radiography, CT, or PET-CT
  • Bone marrow plasma cell burden: Clonal bone marrow plasma cell percentage ≥60%
  • Free light chain ratio: Involved-to-uninvolved free light chain ratio ≥100
  • MRI: >1 focal bony lesion of 5mm or greater on MRI studies

References

  1. 1.0 1.1 1.2 1.3 Rajkumar, S. Vincent, Meletios A. Dimopoulos, Antonio Palumbo, Joan Blade, Giampaolo Merlini, María-Victoria Mateos, Shaji Kumar et al. "International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma." The Lancet Oncology 15, no. 12 (2014): e538-e548

Template:WikiDoc Sources